buying this is a completely different risk conversation from the licensed compounds and that gets said too rarely
#retatrutide 2024-07-17
Wednesday20 messages6 participantstimes are UTC
Highlights from this day
- apob_over_ldl — how do people square the research use only framing with logging their own use 12:24
- apob_over_ldl — GI was about the same as tirzepatide for me, the difference was how fast it arrived, happy to be corrected 12:54
- lot_number_lou — the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me 15:25
no idea whether the heart rate settles for everyone, mine did and one log isnt data
how long before people saw the first change at 7.5
how do people square the research use only framing with logging their own use
😂4⚠️11🔥13
came off at 12 weeks because my resting rate stayed elevated and i didnt like it
🧊1
GI was about the same as tirzepatide for me, the difference was how fast it arrived, happy to be corrected
⚠️7🔥15🙏4
why does everyone insist on smaller steps here than on the other two
stopped for 6 months and restarted at half my old dose, the ramp was easier second time
✅7
how slow is low and slow here, four weeks a step or longer
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
📈1
the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial
triple agonist yeah
the purity spread across lots worries me more than the molecule does
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
Archive lookup: plateau_pen first appears in this channel on 2024-01-01.
held mine ages
the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me
[edited]👍8😂1🧪4
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
follow up appetite suppression at 1.7 was stronger than my tirzepatide experience at a comparable point
cant feel it honestly